The University of Chicago Header Logo

Connection

Robert Rosenfield to Luteinizing Hormone

Back to Details
This is a "connection" page, showing publications Robert Rosenfield has written about Luteinizing Hormone.
Robert Rosenfield
Connection Strength
2.194
Luteinizing Hormone
  1. Blunted sleep-related luteinizing hormone rise in healthy premenarcheal pubertal girls with elevated body mass index. J Clin Endocrinol Metab. 2009 Apr; 94(4):1168-75.
    View in: PubMed
    Score: 0.336
  2. Does a primary acceleration of LH pulse frequency underlie an association between central precocious puberty and polycystic ovary syndrome? Commentary on Escobar ME et al: Acceleration of LH pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism (Horm Res 2007;68:278-285). Horm Res. 2007; 68(6):286-7.
    View in: PubMed
    Score: 0.300
  3. Comparison of detection of normal puberty in girls by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2013 Apr; 98(4):1591-601.
    View in: PubMed
    Score: 0.111
  4. Comparison of detection of normal puberty in boys by a hormonal sleep test and a gonadotropin-releasing hormone agonist test. J Clin Endocrinol Metab. 2012 Dec; 97(12):4596-604.
    View in: PubMed
    Score: 0.108
  5. Is an immunoassay available for the measurement of bioactive LH in serum? J Androl. 1992 Jan-Feb; 13(1):1-10.
    View in: PubMed
    Score: 0.103
  6. Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Res. 2010 Dec 10; 1364:186-97.
    View in: PubMed
    Score: 0.094
  7. Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells. J Clin Invest. 1990 Aug; 86(2):560-5.
    View in: PubMed
    Score: 0.093
  8. Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population. J Clin Endocrinol Metab. 2009 May; 94(5):1579-86.
    View in: PubMed
    Score: 0.084
  9. Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells. Endocrinology. 1988 Aug; 123(2):733-9.
    View in: PubMed
    Score: 0.081
  10. Estradiol inhibition of pituitary luteinizing hormone release is antagonized by serum proteins. J Steroid Biochem. 1986 Sep; 25(3):309-14.
    View in: PubMed
    Score: 0.071
  11. The changing ratio of bioactive to immunoreactive luteinizing hormone (LH) through puberty principally reflects changing LH radioimmunoassay dose-response characteristics. J Clin Endocrinol Metab. 1985 Sep; 61(3):508-13.
    View in: PubMed
    Score: 0.066
  12. Direct inhibitory effect of estradiol on pituitary luteinizing hormone responsiveness to luteinizing hormone releasing hormone is specific and of rapid onset. Biol Reprod. 1984 Feb; 30(1):59-66.
    View in: PubMed
    Score: 0.059
  13. The role of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum Reprod. 2002 Jan; 17(1):88-91.
    View in: PubMed
    Score: 0.051
  14. Gonadotropin-releasing hormone infusion test in the distinction of hypopituitary patients from normal subjects. Fertil Steril. 1979 May; 31(5):507-12.
    View in: PubMed
    Score: 0.043
  15. Is polycystic ovary syndrome a neuroendocrine or an ovarian disorder? Clin Endocrinol (Oxf). 1997 Oct; 47(4):423-4.
    View in: PubMed
    Score: 0.038
  16. The relationship between plasma testosterone and mean LH levels in men. J Clin Endocrinol Metab. 1977 Jul; 45(1):30-4.
    View in: PubMed
    Score: 0.038
  17. Current concepts of polycystic ovary syndrome. Baillieres Clin Obstet Gynaecol. 1997 Jun; 11(2):307-33.
    View in: PubMed
    Score: 0.037
  18. Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor--a clinical research center study. J Clin Endocrinol Metab. 1996 Oct; 81(10):3802-6.
    View in: PubMed
    Score: 0.036
  19. Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin--a clinical research center study. J Clin Endocrinol Metab. 1996 Sep; 81(9):3408-11.
    View in: PubMed
    Score: 0.035
  20. Gonadotropin releasing hormone agonist (nafarelin) test to differentiate gonadotropin deficiency from constitutionally delayed puberty in teen-age boys--a clinical research center study. J Clin Endocrinol Metab. 1995 Oct; 80(10):2980-6.
    View in: PubMed
    Score: 0.033
  21. Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism. J Clin Endocrinol Metab. 1994 Dec; 79(6):1686-92.
    View in: PubMed
    Score: 0.031
  22. Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. J Clin Endocrinol Metab. 1994 Jun; 78(6):1336-40.
    View in: PubMed
    Score: 0.030
  23. Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girls. Clin Obstet Gynecol. 1993 Sep; 36(3):773-85.
    View in: PubMed
    Score: 0.029
  24. Gonadotropin-releasing hormone agonist as a probe for the pathogenesis and diagnosis of ovarian hyperandrogenism. Ann N Y Acad Sci. 1993 May 28; 687:162-81.
    View in: PubMed
    Score: 0.028
  25. Maturation of gonadotropin and sex steroid responses to gonadotropin-releasing hormone agonist in males. J Clin Endocrinol Metab. 1993 Feb; 76(2):362-6.
    View in: PubMed
    Score: 0.028
  26. Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics. 2009 Apr; 123(4):e752-62.
    View in: PubMed
    Score: 0.021
  27. The polycystic ovary syndrome: pathogenesis and treatment. Ann Intern Med. 1989 Mar 01; 110(5):386-99.
    View in: PubMed
    Score: 0.021
  28. The rapid ovarian secretory response to pituitary stimulation by the gonadotropin-releasing hormone agonist nafarelin in sexual precocity. J Clin Endocrinol Metab. 1986 Dec; 63(6):1386-9.
    View in: PubMed
    Score: 0.018
  29. Plasma free testosterone in the diagnosis of adolescent polycystic ovary syndrome. J Pediatr. 1983 Mar; 102(3):461-4.
    View in: PubMed
    Score: 0.014
  30. Bioactive luteinizing hormone pituitary reserves during normal and abnormal male puberty. J Clin Endocrinol Metab. 1982 Jul; 55(1):140-6.
    View in: PubMed
    Score: 0.013
  31. LH bioactivity increases more than immunoreactivity during puberty. J Pediatr. 1980 Aug; 97(2):205-13.
    View in: PubMed
    Score: 0.012
  32. Bioactive LH: a test to discriminate true precocious puberty from premature thelarche and adrenarche. J Pediatr. 1980 Aug; 97(2):214-6.
    View in: PubMed
    Score: 0.012
  33. Reduction of the potency of luteinizing hormone by estrogen. N Engl J Med. 1979 May 03; 300(18):1034-6.
    View in: PubMed
    Score: 0.011
  34. Direct inhibition of Leydig cell function by estradiol. J Clin Endocrinol Metab. 1978 Dec; 47(6):1368-73.
    View in: PubMed
    Score: 0.010
  35. Partial gonadotrophin-resistance in pseudohypoparathyroidism. Acta Endocrinol (Copenh). 1978 Jun; 88(2):321-8.
    View in: PubMed
    Score: 0.010
  36. Experimental cryptorchidism in adult male rats: histological and hormonal sequelae. Anat Rec. 1977 Sep; 189(1):1-27.
    View in: PubMed
    Score: 0.010
  37. The effects of fluoxymesterone administration on testicular function. J Clin Endocrinol Metab. 1977 Jan; 44(1):121-9.
    View in: PubMed
    Score: 0.009
  38. Androgens and ovarian structure in constant oestrus. J Endocrinol. 1975 May; 65(2):283-4.
    View in: PubMed
    Score: 0.008
  39. The effects of prolonged physiologic estradiol therapy on the maturation of hypogonadal teen-agers. J Pediatr. 1974 Dec; 85(6):830-7.
    View in: PubMed
    Score: 0.008
  40. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab. 1994 Nov; 79(5):1328-33.
    View in: PubMed
    Score: 0.008
  41. The effects of low doses of depot estradiol and testosterone in teenagers with ovarian failure and Turner's syndrome. J Clin Endocrinol Metab. 1973 Oct; 37(4):574-80.
    View in: PubMed
    Score: 0.007
  42. Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med. 1992 Jul 16; 327(3):157-62.
    View in: PubMed
    Score: 0.007
  43. Serum testosterone as an index of gonadotrophin secretion in acromegaly and pituitary disease. Acta Endocrinol (Copenh). 1970 Oct; 65(2):302-8.
    View in: PubMed
    Score: 0.006
  44. Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr. 1990 Sep; 117(3):364-70.
    View in: PubMed
    Score: 0.006
  45. A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies. J Clin Endocrinol Metab. 1989 Nov; 69(5):963-7.
    View in: PubMed
    Score: 0.006
  46. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med. 1989 Mar 02; 320(9):559-65.
    View in: PubMed
    Score: 0.005
  47. Parameters of response to clompiphene citrate in oligospermic men. J Urol. 1980 Jul; 124(1):53-5.
    View in: PubMed
    Score: 0.003
  48. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol. 1977 Jan; 49(1):1-8.
    View in: PubMed
    Score: 0.002
  49. Endocrinologic characteristics of partial ovarian failure. J Clin Endocrinol Metab. 1976 Aug; 43(2):449-52.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.